Start-Ups
CpG Diagnostics: De-risking Ovarian Cancer Treatment
A Southern California start-up uses a blood test-based method to address glaring gaps in ovarian cancer diagnosis.
Read ArticleColin Miller
Contributing Writer
5 Years of Experience
About
Colin Miller is a staff writer and medtech analyst. Colin focuses on emerging and disruptive medical device technologies within vast therapeutic areas such as women’s health, wound care, neurovascular, critical care, surgical robotics and cardiovascular. Colin attended McGill University in Montreal and graduated from the University of Minnesota.